健康与医疗系统
New malaria vaccine: The key questions answered
The world’s first mass vaccination program against malaria, announced this week, is set to prevent millions of children from catching malaria and thousands dying from this debilitating di...
Dr Danielle Stanisic completed a Bachelor of Science (with First Class Honours) at the University of QLD and undertook her PhD focussing on malaria research at the Queensland Institute of Medical Research with Professor Michael Good. She won the QLD Premier’s Award for her PhD work and was also awarded a Centenary Medal for Distinguished Service to Medical Research. She recently won the 2018 Glycomics Research Excellence Award for Excellence in a Mid-Career Researcher. She has worked on malaria-focused projects in New York (New York University), Papua New Guinea (PNG Institute of Medical Research and Melbourne (WEHI). She is currently an Associate Research Leader at the Institute for Glycomics, Griffith University where she co-leads the Malaria Vaccine Development Program. Her ongoing research has a translational focus and involves transitioning whole parasite vaccine candidates from pre-clinical studies into clinical development and their evaluation in clinical trials. She is also applying vaccine platforms developed within the Malaria Vaccine Program to other parasites of medical and veterinary importance.
最热内容